Your browser doesn't support javascript.
loading
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.
Davidson, Sean M; Boulanger, Chantal M; Aikawa, Elena; Badimon, Lina; Barile, Lucio; Binder, Christoph J; Brisson, Alain; Buzas, Edit; Emanueli, Costanza; Jansen, Felix; Katsur, Miroslava; Lacroix, Romaric; Lim, Sai Kiang; Mackman, Nigel; Mayr, Manuel; Menasché, Philippe; Nieuwland, Rienk; Sahoo, Susmita; Takov, Kaloyan; Thum, Thomas; Vader, Pieter; Wauben, Marca H M; Witwer, Kenneth; Sluijter, Joost P G.
Afiliación
  • Davidson SM; The Hatter Cardiovascular Institute, University College London, WC1E 6HX London, UK.
  • Boulanger CM; Université Paris Cité, Paris-Cardiovascular Research Center, INSERM, Paris, France.
  • Aikawa E; Department of Medicine, Center for Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Badimon L; Cardiovascular Science Program-ICCC, IR-Hospital de la Santa Creu i Santa Pau-IIBSantPau, CiberCV, Autonomous University of Barcelona, Barcelona, Spain.
  • Barile L; Laboratory for Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale and Faculty of Biomedical Sciences, Università Svizzera italiana, 6900 Lugano, Switzerland.
  • Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Brisson A; Molecular Imaging and NanoBioTechnology, UMR-5248-CBMN, CNRS-University of Bordeaux-IPB, Bat. B14, Allée Geoffroy Saint-Hilaire, 33600 Pessac, France.
  • Buzas E; Department of Genetics, Cell- and Immunobiology, Semmelweis University, HCEMM-SU and ELKH-SE Immune Proteogenomics Extracellular Vesicle Research Group, Budapest, Hungary.
  • Emanueli C; National Heart and Lung Institute, Imperial College London, Hammersmith Campus, London W12 0NN, UK.
  • Jansen F; Department of Internal Medicine II, Heart Center, University Hospital Bonn, Bonn, Germany.
  • Katsur M; The Hatter Cardiovascular Institute, University College London, WC1E 6HX London, UK.
  • Lacroix R; Aix Marseille University, INSERM 1263, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Centre de Recherche en CardioVasculaire et Nutrition (C2VN), Marseille, France.
  • Lim SK; Department of Haematology and Vascular Biology, CHU La Conception, APHM, Marseille, France.
  • Mackman N; Institute of Medical Biology and Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
  • Mayr M; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Menasché P; Department of Medicine, UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Nieuwland R; King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.
  • Sahoo S; Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Paris, France.
  • Takov K; Laboratory of Experimental Cardiology, Department of Cardiology, UMC Utrecht Regenerative Medicine Center and Circulatory Health Laboratory, Utrecht University, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Thum T; Vesicle Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Vader P; Laboratory of Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Wauben MHM; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Witwer K; King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.
  • Sluijter JPG; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Cardiovasc Res ; 119(1): 45-63, 2023 03 17.
Article en En | MEDLINE | ID: mdl-35325061
ABSTRACT
Extracellular vesicles (EVs) are nanosized vesicles with a lipid bilayer that are released from cells of the cardiovascular system, and are considered important mediators of intercellular and extracellular communications. Two types of EVs of particular interest are exosomes and microvesicles, which have been identified in all tissue and body fluids and carry a variety of molecules including RNAs, proteins, and lipids. EVs have potential for use in the diagnosis and prognosis of cardiovascular diseases and as new therapeutic agents, particularly in the setting of myocardial infarction and heart failure. Despite their promise, technical challenges related to their small size make it challenging to accurately identify and characterize them, and to study EV-mediated processes. Here, we aim to provide the reader with an overview of the techniques and technologies available for the separation and characterization of EVs from different sources. Methods for determining the protein, RNA, and lipid content of EVs are discussed. The aim of this document is to provide guidance on critical methodological issues and highlight key points for consideration for the investigation of EVs in cardiovascular studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema Cardiovascular / Micropartículas Derivadas de Células / Exosomas / Vesículas Extracelulares / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Cardiovasc Res Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema Cardiovascular / Micropartículas Derivadas de Células / Exosomas / Vesículas Extracelulares / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Cardiovasc Res Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido